Tracking

Igor's call

GLP-1 OZEMPIC 2030

Weight-loss drugs like ozempic: 100 million people on them.

People on Ozempic, Wegovy, Mounjaro, Zepbound or their generic copies by 2030: 100 million worldwide, 50 million in the US, 30 million in India and China on $15-a-month copies, 20 million across Europe, Brazil, Japan and the Gulf.
Overweight or obese adults worldwide: 2 billion when I called it in 2021, 2.5 billion in 2025, 3 billion by 2030, and the US adult obesity rate 39.9% at the 2022 peak, 36.4% in 2026, 30% by 2030, the first fall in 50 years.
Countries where public health insurance pays for Ozempic-class weight-loss drugs by 2030: 20, up from a handful today (US, UK, Netherlands, Japan), Germany still refusing, its law calls them lifestyle drugs.
Food and drink revenue lost to Ozempic-class drugs by 2030: $50 billion a year in the US alone.
Every call dated & public

///Adjacent calls

Healing peptides like bpc-157: 12 humans tested, legal by phone.TrackingWellness hits $12 trillion. The habit becomes the business.TrackingBirth-rate collapse: the world stops replacing itself.Tracking

Ask Igor your own question. 5 free.

Ask Igor